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Abstract  Objective: To determine the prevalence of chlamydial infection in male urethra 
and female cervix of HIV-positive patients based on PCR assay in Teratai Clinic, 
Dr. Hasan Sadikin General Hospital Bandung. 
  Methods: A cross sectional observational study with consecutive sampling 
method, which was conducted in Teratai Clinic during the month of July 2012. 
All participants underwent history taking, physical examination, and PCR assay 
for C. trachomatis. Swab samples were obtained from male urethra and female 
endocervix. 
 
 Results: Eighty one HIV-positive patients, consisted of 48 males and 33 females 
were included in this study. The PCR examination for C. trachomatis was positive 
in 14 of 81 subjects (17.3%), with 10 (20.8%) urethral chlamydial infection in 48 
males and four (12.1%) cervical chlamydial infection in 33 females. 
 
 Conclusions: The study concluded that the prevalence of chlamydial infection in 
male urethra and female cervix of HIV-positive patients were 20.8% and 12.1%, 
respectively. Identifying chlamydial infection based on PCR testing should be 
considered for routine screening test in HIV-positive patients.
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Introduction 
Worldwide, Chlamydia trachomatis is one 
of the most common etiologies for sexually 
transmitted  infection.1 In 2009, 92 million new 
cases of chlamydial infection were reported by 
World Health Organization, including 43 million 
cases in South and South-East Asia.2 Most of 
chlamydial infections are asymptomatic (70% in 
female and 20–30% in male),3 making it difficult 
to diagnose clinically.1 Nowadays, polymerase 
chain reaction (PCR) method has been approved 
by the Food and Drug Administration (FDA) 
as the new gold standard for the diagnosis 
of chlamydial infection.4 In comparison with 
culture, the PCR method has higher sensitivity in 
detecting chlamydial infection (90.4% vs 70.8%) 
which makes it the best method for screening.5 
Acquired immunodeficiency syndrome (AIDS) 
caused by human immunodeficiency virus (HIV) 
has become a great public health concern.6 In 
2009, the United Nations joint program on HIV/
AIDS (UNAIDS) estimated 33.3 million cases 
of HIV infection with 4.1 million cases in South 
and South East Asia.7 Until September 2012, 
Indonesian Ministry of Health reported 92,251 
cases of HIV infections with most of them (50.8%) 
are heterosexually transmitted.8 
The available epidemiological  data showed 
that there is “epidemiological synergy” between 
sexually transmitted infections (STI) and HIV 
transmission.9 HIV transmission will increase 10 
fold in STI and HIV co-infected patient10 and HIV-
positive patient has higher risk of being infected 
with other STIs. High risk sexual behaviors and 
drug abuse are the two main factors causing STI 
and HIV co-infection.11 Both ulcerated and non-
ulcerated STIs may increase the risk of acquiring 
and transmitting HIV.12 Ulcerated STIs increase 
the risk of acquiring HIV 5 to 10 folds, while non-
ulcerated STIs increase the risk 2 to 5 folds.13 
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Although the impact of non-ulcerated STIs is 
smaller than ulcerated STIs, non-ulcerated STIs 
are more commonly found and, therefore, could 
also increase the HIV epidemic.14 
In 2008, it was reported  in a study that the 
prevalence of STI in HIV patients in Washington 
was 8% with 19.4% of them were infected 
by C. trachomatis.15 Meanwhile, in India, the 
prevalence of chlamydial infection in HIV 
patients in 2011 was 7%.16 
Sexually transmitted infections among HIV-
positive patients usually suggest high risk sexual 
behaviors and HIV transmission to uninfected 
population.17 High-risk sexual behavior seems 
to be continually practiced among HIV-positive 
population.12 To decrease associated morbidity 
and prevent the secondary spread of HIV and 
STIs, prevention efforts should focus on HIV-
positive patients who continue to be engaged in 
high-risk sexual practices.
Corrections of high-risk behavior and STI 
management could decrease the risk of HIV 
transmission as it is reported that .viral shedding 
in HIV-positive patients decreased significantly 
after the STIs were treated.18–20 A study on STI 
intervention with syndromic management in 
several populations in Mwanza has shown a 
successful reduction of HIV incidence by 38%.21
Until currently, there has been no study 
conducted on the prevalence of chlamydial 
infection in HIV-positive patients in Indonesia. 
Therefore, this study will be the first one that 
aims to determine the prevalence of chlamydial 
infection in male urethra and female cervix of 
HIV-positive patients in Indonesia.
Methods 
Study population
This study was conducted at Teratai Clinic in 
Dr. Hasan Sadikin General Hospital, Bandung 
during the month of July 2012. Sexually active 
HIV-positive patients attending Teratai Clinic 
were offered to participate in this study. Eighty 
one HIV-positive participants (48 males and 33 
females) were enrolled after written informed 
consent was obtained. Women having her 
menstrual period were excluded from the study. 
The HIV serostatus of the study population 
was determined and confirmed before this study 
according to the National Guideline for HIV/
AIDS. Comprehensive data on characteristics 
and sexual history of the patients were collected 
through history taking and medical records. 
History taking, clinical examination, and specimen 
collections were conducted in Teratai Clinic, 
while the specimen processing was conducted 
in Biology Molecular Laboratory, Microbiology 
Department of Health Research Unit, Faculty of 
Medicine, Universitas Padjadjaran. 
The study was approved by the Ethical 
Committee of Faculty of Medicine, Universitas 
Padjadjaran-Dr. Hasan Sadikin General Hospital 
Bandung.
Specimen collection method
Urethral swab of male patients and endocervical 
swab of female patients were collected using 
specimen collection kit (Roche) and transported 
to the laboratory in Chlamydia transport tubes 
(Roche), on the day of collection. At the laboratory, 
urethral and endocervical swab specimens for 
PCR assay were prepared immediately  according 
to the instruction, frozen at -20 °C, and analyzed 
within 14 days of sampling.
Specimen processing method  
The Roche Amplicor PCR Assay was used (the PCR 
was accomplished with thermocycler). After the 
amplification, the amplified nucleotide sequences 
were detected by an enzyme immunoassay and 
the optical density at wave length 450 nm was 
measured using a spectrophotometer. A positive 
result was defined as a reading above 0.5 while 
the result was considered equivocal when the 
reading is between 0.2 to 0.5. A negative result 
was assigned for a reading below 0.2. Statistical 
analysis was performed using SPSS 17.0
Results 
During the study, 81 HIV-positive participants 
were screened for chlamydial infection. Among 
the 81 patients tested, 14 chlamydial infections 
were identified with 10 in male urethra and 4 in 
cervix. The prevalence of chlamydial infection in 
this study was 17.4%. Meanwhile, the prevalence 
of urethral chlamydial infection in male was 
20.8% and cervical chlamydial infection in female 
was 12.1%. 
A list of the 81 HIV-positive participants in this 
study is presented in Table 1. Male participants 
comprised 59.3% of the total participants and 
69.1% participants were in 25–35 years old 
group. Half of the participants were high-school 
graduates, 43.2% were self employed, and 55.6% 
were married.
Most of participants who were infected 
with Chlamydia was in the age group of 25–35 
years old,  with 17.9% of them were Chlamydia 
positive (Table 2). C. trachomatis was detected 
in 20.8% males and 12.1% females. Both single 
and divorced groups were infected with C. 
trachomatis as many as 27.8%. This number is 
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much higher compared to only 8.9% of married 
group that were infected by C. trachomatis. 
  
Table 1 Baseline Characteristics of Participants
Variable n %
Age (yrs.)
     <25 5 6
     25–35 56 69
     >35 20 25
Sex
     Male 48 59
     Female 33 41
Education
     No education 0 0
     Elementary school 4 5
     Junior High school 4 5
     Senior High school 41 51
     College/university 32 40
Occupation 
     Self employed 35 43
     Civil servant 1 1
     Working class 20 25
     Commercial sex worker 1 1
     Student 1 1
     Not working 23 28
Marital status 
     Single  18 22
     Married 45 56
     Divorced 18 22
Table 3 shows that 17.9% participants with 
the age of sexual debut  of less than 20 years old 
were infected with Chlamydia. This percentage 
is not significantly different from that of the 
participants with the age of sexual debut of more 
than 20 years old. There were 33.3% participants 
with 6 or more lifetime sexual partners were 
Chlamydia positive, which is higher when it is 
compared to only 14.3% participants with 1 
lifetime sexual partners. Condom use behavior 
was also asked to the participants. Almost 
half of the participants included in the study 
admitted that they always use condom. Despite 
this statement, there were still 17.5% of the 
participants who were infected with Chlamydia. 
This means that we have to consider the 
participants’ statement regarding condom use 
more carefully to understand the real condom 
use behavior. 
Table 2 Characteristics of Participants with Positive 
C. trachomatis
Variable
C. trachomatis Total
(+) (-) n
Age (yrs.)
     <25  1 4 5
     25–35 10 46 56
     >35 3 17 20
Sex
     Male 10 38 48
     Female 4 29 33
Marital status
     Single 5 13 18
     Married 4 41 45
     Divorced 5 13 18
Discussion
The overall prevalence of chlamydial infection 
in this study was 17.3%, which was higher than 
any of the previous studies. This is probably due 
to the fact that STI screening is not routinely 
performed for HIV-positive patients in Teratai 
Clinic. Since most of chlamydial infections are 
asymptomatic, most patients did not receive 
appropriate treatment and this could result in 
persistent chlamydial infection.
Several studies on prevalence of chlamydial 
infection using nucleic acid amplification test in 
HIV-positive patients have been conducted with 
varied results. A literature review of 37 clinical 
studies reported that chlamydia was the most 
common STI identified in HIV-positive patients, 
with 5% median prevalence, ranging from 3 to 
10,9%.22
An evaluation on sexually active Inuit women 
living in remote villages in Alaska found that 114 
(23%) of 493 women had cervical infection with C. 
trachomatis.23 As shown in this study, it has been 
repeatedly demonstrated that in sexually active 
populations in which little diagnostic testing and/
or specific treatment is used, the prevalence of 
infection may reach surprisingly high levels. This 
reflects the asymptomatic nature of chlamydial 
infection and the ability of the infection, when 
untreated, to persist for months or years.23 
Phipps reported that the prevalence of 
asymptomatic chlamydial infection in HIV-
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positive patients was 8.3%,24 whereas Iwuji 
reported that the prevalence of chlamydial 
infection was 2.7% in asymptomatic patients and 
19% in symptomatic patients.25
The prevalence of urethral chlamydial 
infections in male participants in this study was 
20.8%. The prevalence was higher than previous 
studies. Several authors reported varying result 
of C. trachomatis prevalence in HIV-positive men. 
The prevalence of chlamydial infection in HIV-
positive men was 7% in India16 and America,15 9% 
in England,25 and 6% in US army.26
In this study the prevalence was higher in 
men than women. This is probably due to the fact 
that most of the patients who came to Teratai 
Clinic are male, and compared to women, men 
have higher tendencies to engage in high risk 
sexual behavior. The risk for chlamydial infection 
was twice higher in men than women.26 This is 
probably due to higher risk sexual practices in 
men. Twenty nine point two percent of men 
admitted having more than 15 sexual partners, 
compared to 11.4% in women.27
A research in 11 cities in Indonesia showed 
that 33% of men had sex with female sex 
worker in the previous year and 20% with non-
marital female partners. This study also showed 
consistent condom use was low in both sex 
workers (17%) and other non-marital partners 
(13%).28 The prevalence of cervical chlamydial 
infections in female participants in this study 
was 12.1%.
Previous studies have reported different 
results of chlamydial prevalence in HIV-positive 
women.18,29,30 The cervical chlamydial infection 
prevalence in women with HIV in 12 European 
countries was 11.8%.29 Research in Thailand 
found that the prevalence of chlamydial 
infection was 9.7% in HIV-positive woman.30  
In an American study, it was reported that the 
prevalence of chlamydial infection was 3.6% in 
HIV-positive women.18
Chlamydial infection in HIV-positive patients 
were found as more common in female, but not 
statistically significant12 which was affirmed by 
another study showing a correlation between 
female sex and chlamydial infection in HIV-
positive patients.31 Women have twice the risk 
of infected with C. trachomatis than men. This is 
probably because women are anatomically more 
vulnerable to STIs. Anatomic considerations 
make the transmission of STIs to women during 
sexual intercourse a biologically “more efficient” 
process. During  intercourse, semen tends to pool 
in the vaginal vault causing prolonged contact 
with cervix epithelium. Another factor is cervical 
ectopy, which is commonly found in prepubertal 
women caused by hormonal changes.27
Norms regarding appropriate sexual behavior 
are usually more restrictive for women than for 
men in most societies. These norms not only 
limit women’s sexual freedom but also restrict 
their access to information about sexuality. In 
addition, lack of economic independence may 
prevent women from leaving a relationship that 
puts them at risk for acquiring STIs. In many 
countries, wives have little control over marital 
sexuality and women’s ability to negotiate safer 
sexual practices, particularly condom use, is 
practically none.32
In this study, the average age of participants 
infected with C. trachomatis was 33.6 (34) years 
old, with a range of 23 to 71 years old. Most 
participants were in the age of 25–35 years old.
Most authors confirmed young age as a risk 
factor for chlamydial infection.11,18,31 Young age 
was significantly related to the risk for acquiring 
STI in HIV-positive patients.11 While another 
studies showed that an age of <35 years old 
with HIV positive were at risk of being infected 
with chlamydia.18,31 One study stated that the 
prevalence of chlamydial infection in <25, 25–
35, and >35 years old were 6.3%, 4.8%, 1.9%, 
consecutively.18
Several factors that contributed to young age 
as a risk factor for acquiring chlamydial infection 
include higher number of sexual partners15 and 
less concerns about the risk of contracting HIV 
which lead to inadequate use of protective 
measures despite knowledge of HIV-positive 
status.26 Onen reported that recent sexual 
activities decreased with increasing age which 
may be due to a number of factors, including 
partner availability, relationship satisfactory, 
social isolation, bereavement plus perceived 
ageism, and stigmatization. The presence of 
physical and medical illness can also impact 
sexual function and was a factor independently 
and negatively associated with recent sexual 
activity.15 Contrary to other studies, Iwuji found 
that age is not related with chlamydial infections 
in HIV-positive men.25
Most authors discovered that chlamydial 
infection is related with sexual behavior. It is also 
reported that high risk sexual behavior increased 
the risk for acquiring chlamydial infection 
significantly.33
Contrary to other studies, Lee found no 
significant relation between sexual behavior 
and STI incident in HIV-positive patients.11 This is 
probably due to bias. Many studies that observed 
sexual behavior frequently gave inaccurate 
result, because of recall and social desirability 
bias.34
Sexual histories discussed in this study are 
age of sexual debut, number of sexual partners, 
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condom use, and STI history. In this study, the 
average age of sexual debut in chlamydial 
infected participants is 19 years old, with 7 of 14 
participants infected with C. trachomatis having 
sexual debut at the age of <20 years old. This 
result is in accordance with the results from a 
study by Ghosh who found the risk for acquiring 
chlamydial infection in HIV-positive patients 
increased in patients with age of sexual debut 
<20 years old.16
Young sexual debut, particularly in men is 
correlated with increased number of sexual 
partners, while in women this correlates with 
early marriage and sexual coercion. Sexual 
coercion is related to big age difference, 
infrequent condom use, and high STI risk.32 In 
this study, 6/27 of participants claimed not 
having sexual intercourse in the last month and 
4/20 in the last three months infected with C. 
trachomatis. 
Fifty percent of homosexual and 22% women 
who admitted not having sexual intercourse in 
the last three months were infected with STI.34 
This may be due to several reasons, including 
recall and social desirability bias in reporting34 
and persistent chlamydial infection transmitted 
through sexual encounters >3 months before.15 
Most of chlamydial infections are asymptomatic. 
Therefore, if routine screening was not done, 
most of infections would not be treated and 
could persist months or even years.23 Most of 
chlamydial infected participants in this study had 
≥6 lifetime sexual partners.
Several authors found that the number of 
sexual partners correlated with chlamydial 
infection.35,36 Findings show that increased 
number of sexual partners would increase the 
risk for acquiring chlamydial infection35 and ≥6 
sexual partners would increased the risk for 
acquiring chlamydial infection 13.5 times in 
women and 5.3 times in men.36
Most of participants in this study claimed 
always using condom in every sexual intercourse. 
Seventeen point five percent (7/40) of the 
participants who claimed that they always use 
condom were infected by C. trachomatis. Several 
authors reported conflicting results about 
condom use in chlamydial infection.11,34 One 
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Table 3 Sexual History of Participants with Positive C. trachomatis
Variable
C. trachomatis Total
(+) (-) n
Age of sexual debut (yrs.)
     <20 7 32 39
     ≥20 7 35 42
Number of sexual partner in the last month
     0 person 6 21 27
     1 person 6 42 48
     ≥2 persons 2 4 6
Number of sexual partner in the last 3 months
     0 person 4 16 20
     1 person 7 39 46
     ≥2 persons 3 12 15
Number of lifetime sexual partner 
     1 person 3 18 21
     2–5 persons 4 35 39
     ≥6 persons 7 14 21
Condom use 
     Never 4 16 20
     Seldom 3 18 21
     Always 7 33 40
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study found no correlation between condom 
use and incident of chlamydial infection11 while 
another study found that 20% of patients who 
always use condom were infected with STI.34 
Most patients infected with Chlamydia claimed 
that they always use condom in the previous 
week.35 This finding may be influenced by several 
factors, including recall and reporting bias, 
inconsistent and inappropriate condom use,33 or 
latent chlamydial infection.23
Contrary to other studies discussed above, 
van Benthem found that inconsistent condom 
use with casual sex partners increased the risk 
for acquiring chlamydial infection in HIV-positive 
patients. HIV-positive women who used condoms 
in less than 50% of their sexual contacts with 
casual partners had almost eight-fold higher risk 
and those who used condoms in 50–99% of the 
contacts had two-fold higher risk than women 
who did not have a casual partner.29 
Based on the discussion in this paper, It is 
concluded that the prevalence of chlamydial 
infection in male urethra and female cervix of 
HIV-positive patients in Teratai Clinic, Dr. Hasan 
Sadikin General Hospital Bandung were 20.8% 
and 12.1%, consecutively, based on the PCR 
results. Identifying chlamydial infection using 
PCR assay should be considered for routine 
screening test in HIV-positive patients.
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